Relay Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold RLAY, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
25
Funds holding
$304949736
Total value held
Buying
19 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $129104225 | 12975299 | -253203 | -1.91% |
| 2 | State Street Corp | $62023773 | 6233545 | -192566 | -3.00% |
| 3 | Goldman Sachs Group Inc | $25291517 | 2541861 | +682227 | +36.69% |
| 4 | Bank Of America Corp /De/ | $19280066 | 1937695 | +896746 | +86.15% |
| 5 | Northern Trust Corp | $16670101 | 1675387 | +536699 | +47.13% |
| 6 | Alphabet Inc. | $15563521 | 1564173 | -4580 | -0.29% |
| 7 | Morgan Stanley | $14248431 | 1432003 | -586461 | -29.05% |
| 8 | Invesco Ltd. | $7321970 | 865481 | +504291 | +139.62% |
| 9 | Bank Of New York Mellon Corp | $3810052 | 382920 | +4217 | +1.11% |
| 10 | Ameriprise Financial Inc | $3551394 | 356924 | — | NEW BUY |
| 11 | Raymond James Financial Inc | $3445855 | 346317 | +86906 | +33.50% |
| 12 | Wells Fargo & Company/Mn | $1335766 | 157892 | +56352 | +55.50% |
| 13 | Janus Henderson Group Plc | $652123 | 65573 | — | NEW BUY |
| 14 | Bank Of Montreal /Can/ | $526783 | 52943 | — | NEW BUY |
| 15 | Franklin Resources Inc | $486704 | 48915 | — | Held |
| 16 | Barclays Plc | $450407 | 45267 | — | NEW BUY |
| 17 | Sei Investments Co | $359494 | 36130 | — | NEW BUY |
| 18 | Citigroup Inc | $261668 | 30930 | +16616 | +116.08% |
| 19 | Nomura Holdings Inc | $248750 | 25000 | — | NEW BUY |
| 20 | Prudential Financial Inc | $212433 | 21350 | — | NEW BUY |
| 21 | Us Bancorp \De\ | $52058 | 5232 | +101 | +1.97% |
| 22 | Pnc Financial Services Group, Inc. | $44706 | 4493 | -113 | -2.45% |
| 23 | Fifth Third Bancorp | $6607 | 664 | — | NEW BUY |
| 24 | Royal Bank Of Canada | $1000 | 146 | — | NEW BUY |
| 25 | Amalgamated Financial Corp. | $332 | 11087 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.